HYSCX | PHYQX | HYSCX / PHYQX | |
Total Expense Ratio | 1.75 | 0.38 | 461% |
Annual Report Gross Expense Ratio | 1.81 | 0.38 | 476% |
Fund Existence | 13 years | 14 years | - |
Gain YTD | 5.661 | 7.831 | 72% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.16B | 21.1B | 24% |
Annual Yield % from dividends | 5.67 | 7.30 | 78% |
Returns for 1 year | 5.64 | 7.91 | 71% |
Returns for 3 years | 25.01 | 33.63 | 74% |
Returns for 5 years | 25.33 | 29.08 | 87% |
Returns for 10 years | 51.90 | 80.42 | 65% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTDX | 136.83 | 1.03 | +0.76% |
Franklin Biotechnology Discovery C | |||
TRSYX | 17.47 | 0.13 | +0.75% |
T. Rowe Price Small-Cap Index | |||
VFAIX | 65.63 | 0.48 | +0.74% |
Vanguard Financials Index Admiral | |||
STRLX | 62.85 | 0.38 | +0.61% |
Sterling Capital MdCp Relatv Val A | |||
OPMIX | 35.75 | 0.02 | +0.06% |
Invesco Main Street Mid Cap R6 |